Open AccessStudy of endovascular treatment in obstructive aortoiliac lesions: Immediate and short-term results
Author(s) -
D. C. Joshi,
Tarun Madan,
Riyaz Charaniya,
Pratik Raval,
Krutika Patel,
Ajinkya Borhade,
Rujuta Parikh,
Anand Dhakne
Publication year - 2021
Publication title -
heart, vessels and transplantation
Language(s) - English
Resource type - Journals
eISSN - 1694-7894
pISSN - 1694-7886
DOI - 10.24969/hvt.2022.298
Subject(s) - medicine , gangrene , surgery , stent , claudication , aortoiliac occlusive disease , intermittent claudication , endovascular treatment , radiology , arterial disease , vascular disease , aneurysm
Objective: Aorto-iliac occlusive disease (AIOD) is a common atherosclerotic disease causing significant morbidity. Transatlantic intersociety consensus for the management of peripheral arterial disease (TASC II) recommends endovascular therapy (ET) for better management of patients with lesions type A and B. With the advent of endovascular therapy, type C and D lesions management is becoming more feasible with endovascular therapy than open surgery for aorto-iliac occlusive disease. We aimed to evaluate patients with AIOD and to describe short-term outcome of endovascular treatment for such lesions.Methods: Patients with aorto-iliac occlusive diseases who underwent endovascular therapy were enrolled in the study. Their demographic data and risk factors were recorded. Patients were followed at 3 and 6 months and their primary patency rate and symptom status were recorded.Results: We enrolled 100 patients with a mean age of 59.77 (8.75) years with the majority of patients being male. The most common presentation was claudication (59%) followed by rest pain (31%) and gangrene (20%). The majority of patients had Transatlantic inter-society consensus (TASC) II type A (44%) and type B (31%) lesions; 15% of patients had types C lesions and the remaining 10% patients had type D lesions. Access site hematoma and contrast-induced nephropathy were present in 7% and 5% of patients respectively. Stent patency rate was 97% and 95% at 3 and 6 months follow up respectively.Conclusion: Endovascular therapy in aorto-iliac occlusive disease is a safe, effective, and low-cost treatment option with a high patency rate and symptomatic improvement in the short-term.